Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by James M. Mountz
Repeatability of 18 F-FLT PET in a Multicenter Study of Patients With High-Grade Glioma
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Combined Imaging Biomarkers for Therapy Evaluation in Glioblastoma Multiforme: Correlating Sodium MRI and F-18 FLT PET on a Voxel-Wise Basis
Magnetic Resonance Imaging
Nuclear Medicine
Radiology
Biomedical Engineering
Imaging
Biophysics
Related publications
Repeatability of Quantitative 18f-NaF PET: A Multicenter Study
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
[18 F]-FDG PET/CT in the Staging and Management of Indolent Lymphoma: A Prospective Multicenter PET Registry Study
Cancer
Cancer Research
Oncology
Use of Metformin and Survival of Patients With High-Grade Glioma
International Journal of Cancer
Cancer Research
Oncology
Validation of 18 F-FLT PET as an Imaging Surrogate of Tumor Reproliferation During Fractionated Radiation Therapy: Spatial Coincidence of 8 F-FLT Uptake and Immunohistochemistry Ki-67
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Fluorothymidine Positron Emission Tomography (FLT-PET) Repeatability and Response Evaluation in Advanced Pancreatic Cancer Patients Treated With Gemcitabine-Based Chemotherapy
Clinical Oncology and Research
The Information and Support Needs of Patients Diagnosed With High Grade Glioma
Patient Education and Counseling
Medicine
Supplementary Materials - Fluorothymidine Positron Emission Tomography (FLT-PET) Repeatability and Response Evaluation in Advanced Pancreatic Cancer Patients Treated With Gemcitabine-Based Chemotherapy
Timing of Surgery and Bevacizumab Therapy in Neurosurgical Patients With Recurrent High Grade Glioma
Journal of Clinical Neuroscience
Medicine
Surgery
Neurology
Physiology
A Pilot Study of Peptide Vaccines for VEGF Receptor 1 and 2 in Patients With Recurrent/Progressive High Grade Glioma
Oncotarget
Oncology